INTRODUCTION
============

Large yellow croaker (*Larimichthys crocea*) is an economically important marine species of cultured fish ([@b25-ZoolRes-37-6-347]). However, the aquaculture of large yellow croaker has suffered significant economic losses due to various infectious diseases caused by marine microorganisms such as *Vibrio alginolyticus* ([@b6-ZoolRes-37-6-347]; [@b20-ZoolRes-37-6-347]). *Vibrio alginolyticus* is an important pathogen that can cause disease in marine cultured fish ([@b32-ZoolRes-37-6-347]). Infection leads to the upregulation of inflammatory cytokines, such as interleukin-1β (IL-1β), interleukin-10 (IL-10), and tumor necrosis factor-α (TNF-α) ([@b14-ZoolRes-37-6-347]; [@b28-ZoolRes-37-6-347]; [@b34-ZoolRes-37-6-347]). Infection also increases bacterial burden, which triggers multiple inflammatory mechanisms. Therefore, bacterial burden is an important indicator for innate host immunity in response to infection ([@b12-ZoolRes-37-6-347]). Increased lethality is also observed in various teleosts infected with pathogens ([@b4-ZoolRes-37-6-347]; [@b16-ZoolRes-37-6-347]). Nowadays, a variety of effective vaccines and medicines have been developed to control marine pathogens; however, these drugs often negatively affect the marine environment and fish themselves ([@b3-ZoolRes-37-6-347]). Therefore, there is an increasing demand for effective and environmentally friendly commercial therapeutics against marine microorganisms. In this respect, considerable attention has been paid to antimicrobial polypeptides (AMPs), known as endogenous antibiotics ([@b23-ZoolRes-37-6-347]).

AMPs, a family of peptides and proteins with low molecular weight, are present in virtually all life forms (from prokaryotes to eukaryotic plants and animals) ([@b43-ZoolRes-37-6-347]). These peptides are critical components of the innate immune system in low vertebrate hosts ([@b9-ZoolRes-37-6-347]; [@b15-ZoolRes-37-6-347]). Many AMPs have been identified from fish, including cathelicidin, histone-derived peptides, defensin, and hepcidin ([@b13-ZoolRes-37-6-347]). Piscidin family proteins possess antimicrobial activity and include pleurocidin, moronecidin, chrysophsin, and dicentracin ([@b22-ZoolRes-37-6-347]; [@b39-ZoolRes-37-6-347]). In teleosts, piscidin genes have been cloned and reported in some species, including Atlantic cod (*Gadus morhua*) ([@b11-ZoolRes-37-6-347]; [@b30-ZoolRes-37-6-347]), rock bream (*Oplegnathus fasciatus*) ([@b39-ZoolRes-37-6-347]), tilapia (*Oreochromis niloticus*) ([@b19-ZoolRes-37-6-347]; [@b27-ZoolRes-37-6-347]), hybrid striped bass ([@b26-ZoolRes-37-6-347]; [@b31-ZoolRes-37-6-347]; [@b35-ZoolRes-37-6-347]), and mandarin fish (*Siniperca chuatsi*) ([@b36-ZoolRes-37-6-347]). The piscidin gene shares a common prepropeptide structure consisting of a signal peptide, a mature peptide, and a C-terminal prodomain of varied sequence and length ([@b15-ZoolRes-37-6-347]; [@b36-ZoolRes-37-6-347]). As the major class of AMPs, piscidin displays potent broad-spectrum activity against bacteria ([@b35-ZoolRes-37-6-347]), fungi ([@b37-ZoolRes-37-6-347]), parasites ([@b8-ZoolRes-37-6-347]), and even viruses ([@b7-ZoolRes-37-6-347]).

Recently, a piscidin-like antimicrobial peptide was isolated from large yellow croaker, and was determined to be a typical gill-expressed peptide distributed in various tissues ([@b25-ZoolRes-37-6-347]). Furthermore, two types of *piscidin-5*-*like* sequences have been found in large yellow croaker, with their gene structure and sequence characteristics described ([@b44-ZoolRes-37-6-347]). The large yellow croaker *piscidin-5*-*like* gene and hybrid striped bass *piscidin-5* gene are reported to be most abundant in the head kidney and intestine, respectively ([@b31-ZoolRes-37-6-347]; [@b44-ZoolRes-37-6-347]). The synthetic piscidin-4 peptide of hybrid striped bass shows antimicrobial activity against *Staphy lococcus aureus*, *Streptococcus iniae*, *Escherichia coli*, and *V. anguillarum* ([@b26-ZoolRes-37-6-347]), and the synthetic piscidin-like peptide of large yellow croaker exhibits broad antimicrobial activity against *S. aureus*, *E. coli*, *Aspergillus niger*, and *Cryptocaryon irritans* in parasitic stages ([@b25-ZoolRes-37-6-347]). These results show the high diversity of piscidin in mRNA expression and function in different fish. However, the effects of teleost piscidin on host defenses against pathogens *in vivo* are still unclear.

In this study, we characterized the cDNA sequence encoding a piscidin-like peptide, *Lcpis5lt3*, from large yellow croaker. Its mRNA expression in different tissues post *V. alginolyticus* infection was studied using quantitative PCR. In addition, the antimicrobial activity of synthetic peptides was also investigated *in vitro* and *in vivo*.

MATERIALS AND METHODS
=====================

Fish rearing
------------

Healthy large yellow croaker, without pathological signs and weighing 35-40 g (fish age 7-9 months), were obtained from a commercial farm in Ningbo, China. Each 10 fish were kept in 100 L tanks at 25-27℃ in a recirculating system with filtered sea water. Detection was performed to ensure no bacteria were present in the seawater during the experiment. After acclimating for one week, the fish were used in the experiments described below. All experiments were approved by the Experimental Animal Management Law of China and the Animal Ethics Committee of Ningbo University.

Bacterial challenge
-------------------

Overnight cultures of *V. alginolyticus* ATCC 17749 were diluted to 1: 100 in Tryptic Soy Broth Medium (TSB) (Sigma, Shanghai, China), grown at 28℃ with shaking, and harvested in the logarithmic phase of growth. The cells were washed, resuspended, and diluted to the appropriate concentration in sterile PBS. Sixteen fish were challenged by intraperitoneal injection with 5×10^6^ colony forming units (CFUs) of *V. alginolyticus* (in 100 μL PBS) per fish, and sixteen other fish were injected with 100 μL of PBS per fish as a negative control. The liver, spleen, head kidney, kidney, intestine, muscle, brain, and gill were collected from four fish at each time point at 4, 8, 12, and 24 h post-injection (hpi), as previously reported ([@b42-ZoolRes-37-6-347]), then preserved at -70℃ until examination.

Sequence analysis
-----------------

Gene sequences used for multiple alignment and phylogenetic analysis are listed in [Table 1](#T1-ZoolRes-37-6-347){ref-type="table"}. The similarity between the obtained sequences with other known sequences was analyzed using BLAST search (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>). The cleavage site of signal peptides was predicted by the SignalP4.1 program (<http://www.cbs.dtu.dk/services/SignalP/>). Protein analysis was performed using online software on the ExPASy Server (<http://www.expasy.org/tools/>). Multiple sequence alignment was analyzed using the ClustalW program (<http://clustalw.ddbj.nig.ac.jp/>), and phylogenetic and molecular evolutionary analyses were conducted using MEGA version 5.0 ([@b38-ZoolRes-37-6-347]).

###### 

Piscidin sequences used for multiple sequence alignment and phylogenetic tree analysis

  Species                        Gene                     GenBank ID     
  ------------------------------ ------------------------ -------------- ----------
  *Larimichthys crocea*          Large yellow croaker     Piscidin5lt3   KX870851
  *Larimichthys crocea*          Large yellow croaker     Piscidin5lt2   KJ879923
  *Larimichthys crocea*          Large yellow croaker     Piscidin5l     KJ879922
  *Larimichthys crocea*          Large yellow croaker     Piscidin l     EU741827
  *Oplegnathus fasciatus*        Rock bream               Piscidin       AB703274
  *Epinephelus malabaricus*      Malabar grouper          Piscidin1      JX412481
  *Epinephelus malabaricus*      Malabar grouper          Piscidin2      JX412480
  *Epinephelus coioides*         Orange spotted grouper   Piscidin       JQ823163
  *Epinephelus coioides*         Orange spotted grouper   Piscidin l     EU741829
  *Epinephelus bruneus*          Longtooth grouper        Piscidin l     JN216987
  *Epinephelus bleekeri*         Duskytail grouper        Piscidin l     HQ437912
  *Epinephelus fuscoguttatus*    Brown marbled grouper    Piscidin l     GU592793
  *Epinephelus akaara*           Red spotted grouper      Piscidin l     EU741828
  *Morone chrysops*              White bass               Piscidin1      AF394243
  *Morone saxatilis*             Striped bass             Piscidin2      AF394244
  *M. chrysops × M. saxatilis*   Hybrid striped bass      Piscidin4      HM596029
  *M. chrysops × M. saxatilis*   Hybrid striped bass      Piscidin5      HM596030
  *Dicentrarchus labrax*         European sea bass        Dicentracin    AY303949
  *Siniperca chuatsi*            Mandarin fish            Moronecidin    AY647433

Quantitative PCR (qPCR)
-----------------------

Changes in mRNA expression of *Lcpis5lt3* following *V. alginolyticus* infection were analyzed by qPCR, as previously described ([@b21-ZoolRes-37-6-347]; [@b42-ZoolRes-37-6-347]). Total RNA was extracted from large yellow croaker tissues using RNAiso reagents (TaKaRa). Gene-specific primers were designed based on the cloned cDNA fragments of Lcpis5lt3, LcIL-1β, LcTNF-α, and LcIL-10 ([Table 2](#T2-ZoolRes-37-6-347){ref-type="table"}). Lcpis5lt3 and two types of piscidin-5-like gene sequences were subjected to nucleotide sequence alignment, and the primers of Lcpis5lt3 were designed in the ORF region of a 153-262 bp portion with low sequence identity. BLAST searching indicated that these primer sequences did not share sequence homology with any known large yellow croaker gene sequence, per the large yellow croaker genome ([@b41-ZoolRes-37-6-347]). As an internal PCR control, primers 18S rRNA F and 18S rRNA R were used to amplify a 200-bp fragment of the housekeeping large yellow croaker 18S rRNA (Lc18S rRNA) gene (Accession No. JN211788.1) ([Table 2](#T2-ZoolRes-37-6-347){ref-type="table"}). QPCR was conducted on an ABI StepOne Real-Time PCR System (Applied Biosystems, USA) using SYBR premix Ex Taq (Perfect Real Time) (TaKaRa) in accordance with the manufacturer\'s instructions. The reaction mixture was incubated for 300 s at 95℃, followed by 40 amplification cycles of 30 s at 95℃, 30 s at 60℃, and 30 s at 72℃. After amplification, melt curves were obtained by slow heating from 60℃ to 95℃ at 0.1℃/s, with continuous fluorescence collection, confirming that only our specific product peaks were detected. Fish were kept in eight aquaria. Two fish in each aquarium were biologically repeated twice, and the fish experiment was repeated once, for a total of four biological replicates. The mRNA expression of Lcpis5lt3 was normalized against that of 18S rRNA using the 2^-ΔΔCT^ method.

###### 

Oligonucleotide primers used in this work

  Gene         Primer         Sequence (5\'-3\')     Amplification of length (bp)   Tm (℃)
  ------------ -------------- ---------------------- ------------------------------ --------
  Lcpis5lt3    Lcpis5lt3 F    ATTGTATCGATCTCGCTGGC   101                            58
               Lcpis5lt3 R    CATAATTGGGTGGAAAACGG                                  55
  Lc18S rRNA   Lc18S rRNA F   CTCTTAGCTGAGTGTCCCGC   200                            60
               Lc18S rRNA R   ACCTCTAGCGGCACAATACG                                  60
  LcIL-1β      LcIL-1β F      ATCTGGCAAGGATCAGCTCA   108                            59
               LcIL-1β R      ACCAGTTGTTGTAGGGGACG                                  60
  LcTNF-α      LcTNF-α F      TGGAGTGGAAGAACGGTCAA   173                            59
               LcTNF-α R      GAGAGGTGTGAGGCGTTTCC                                  61
  LcIL-10      LcIL-10 F      CAAGAGCATGAAGCCTCACA   169                            58
               LcIL-10 R      GCCCACGGCCTTAAATAGAC                                  59

Antimicrobial activity assays
-----------------------------

The mature peptide of Lcpis5lt3 was chemically synthesized with over 95% purity (GL Biochem, Shanghai, China). The antimicrobial activity was determined against a panel of microorganisms. A micro-dilution assay was used to determine the minimal inhibitory concentration (MIC) of the various agents, as previously described with some modification ([@b18-ZoolRes-37-6-347]). Inhibition was defined as growth lesser or equal to one-half of the growth observed in control wells where no peptide was added ([@b10-ZoolRes-37-6-347]). Briefly, serial dilutions of the peptides were made at 100, 50, 25, 12.5, 6.25, 3.125, and 1.563 μg/mL in 96-well microtiter plates. Each well contained 100 μL of a bacterial cell suspension at 1×10^5^ CFU/mL and 11 μL of test peptide. After incubating for 24 h at the appropriate temperature, microbial growth was examined. All tests were performed in triplicate and each individual experiment was replicated in quadruplicate. For each series of experiments, PBS was employed as a negative control.

Fish survival assay
-------------------

Fish were divided into three groups (each containing 16 fish) for survival assay. Fish were injected intraperitoneally (ip) with 5×10^6^ CFU/g *V. alginolyticus*. After 30 min, fish received ip injections of 1.0 μg/g Lcpis5lt3 or 0.1 μg/g Lcpis5lt3 of fish weight, while the control group received PBS 30 min post injection. Fish were observed every 24 h for death or moribund state for 8 d.

Bacterial burden in tissues
---------------------------

Three groups, each containing six fish, were ip-injected with *V. alginolyticus* (5×10^6^ CFU/g). At 30 min post-infection, the fish received ip injections of different doses of Lcpis5lt3 or PBS, respectively. Fish were sacrificed 12 h after ip injection, and the liver, kidney, spleen, and blood were collected. The tissues from each large yellow croaker were weighed and homogenized in 1 mL of sterile PBS (pH 7.2). Homogenates and blood were serially diluted in sterile PBS (pH 7.2) and then plated onto separate Thiosulfate Citrate Bile Salts (TCBS) agar plates for 18 h at 28℃. CFUs were then calculated in all plates and multiplied by the dilution factor. Tissue samples were normalized to tissue weight (0.1 g), and blood samples were normalized to blood volume (0.1 mL).

Statistical analysis
--------------------

All data were described as mean±SEM. Statistical analysis of results was conducted by one-way analysis of variance (ANOVA) with SPSS version 13.0 (SPSS Inc, Chicago, USA). *P*-values of less than 0.05 were considered statistically significant.

RESULTS
=======

*Lcpis5lt3* gene analysis
-------------------------

Using the liver transcriptome analysis of large yellow croaker, the cDNA sequence of the *Lcpis5lt3* gene was identified by BLAST search and submitted to the DDBJ/EMBL/GenBank databases under accession number KX870851. Computer analysis showed that the large yellow croaker *pis5lt3*, *piscidin-5*-*like*, and *piscidin-5*-*like type 2* cDNA sequences contained open reading frames (ORFs) of 264 bp, 213 bp, and 210 bp that encoded an 88, 71, and 70 amino acid peptide, respectively. The peptide of Lcpis5lt3 had an estimated molecular weight (MW) of 9.78 kDa and theoretical isoelectric point (pI) of 8.93. All piscidin-5s were comprised of an N-terminal signal peptide (22 amino acids), a mature peptide (22 amino acids), and a C-terminal prodomain ([Figure 1](#F1-ZoolRes-37-6-347){ref-type="fig"}). The deduced cleavage site for the signal peptide was between positions 22 and 23 (GEC-LG), like that of most piscidin sequences referenced, terminating at the motif GEC, GES, or GEG ([Figure 1](#F1-ZoolRes-37-6-347){ref-type="fig"}) ([@b10-ZoolRes-37-6-347]). However, the peptide length of Lcpis5lt3 was longer than that of piscidin-5-like type 2 and piscidin-5-like.

![Multiple alignment of the predicted Lcpis5lt3 amino acid sequence with other known piscidins](ZoolRes-37-6-347-g1){#F1-ZoolRes-37-6-347}

Amino acid sequence alignment of Lcpis5lt3 with closely related sequences revealed conservation in the signal peptide region ([Figure 1](#F1-ZoolRes-37-6-347){ref-type="fig"}), but low similarity in the mature peptide and prodomain. In general, Lcpis5lt3 showed low identity (less than 62.5%) to other known piscidin sequences. Based on the known fish piscidin amino acid sequences, a phylogenetic tree was constructed using the neighbor-joining method ([Figure 2](#F2-ZoolRes-37-6-347){ref-type="fig"}). Results showed that Lcpis5lt3 and other large yellow croaker piscidin-5s grouped together to form a large yellow croaker piscidin-5 cluster.

![Phylogenetic (neighbor-joining) analysis of the complete amino acid sequences of a piscidin protein using the MEGA5.0 program](ZoolRes-37-6-347-g2){#F2-ZoolRes-37-6-347}

Antimicrobial spectrum
----------------------

The antibacterial activity of the synthesized mature peptide was determined against a panel of microorganisms using the MIC method. The MIC values obtained are reported in [Table 3](#T3-ZoolRes-37-6-347){ref-type="table"}. The synthesized mature peptide of Lcpis5lt3 exhibited activity against *Aeromonas hydrophila*, *V. anguillarum*, *and V. alginolyticus* at 100 μg/mL. It also displayed antibacterial activity with MICs at 50 μg/mL and 6.25 μg/mL against *V. parahaemolyticus* and *S. aureus*, respectively. Lcpis5lt3 had antibacterial activity against *Listeria monocytogenes* with MIC at 3.125 μg/mL. However, this peptide had no effect on *Edwardsiella tarda*, *V. vulnificus*, *V. harveyi*, or *S. iniae* at the concentration tested.

###### 

Antimicrobial activity of synthetic Lcpis5lt3

  Bacteria                    Strains     Culture medium   Culture temperature (℃)   Lcpis5lt3 MIC (μg/mL)
  --------------------------- ----------- ---------------- ------------------------- -----------------------
  *Edwardsiella tarda*        Et-CD       LB               37                        \-
  *Aeromonas hydrophila*      ATCC7966    LB               37                        100
  *Staphylococcus aureus*     ATCC6538    LB               37                        6.25
  *Listeria monocytogenes*    ATCC19115   BHI              37                        3.125
  *Vibrio anguillarum*        ATCC19264   TSB              28                        100
  *Vibrio alginolyticus*      ATCC17749   TSB              28                        100
  *Vibrio vulnificus*         ATCC27562   TSB              28                        \-
  *Vibrio parahaemolyticus*   ATCC33847   TSB              28                        50
  *Vibrio harveyi*            ATCC33866   TSB              28                        \-
  *Streptococcus iniae*       ATCC29178   BHI              37                        \-

\"-\" Means no inhibition found at 100 μg/mL.

Constitutive and induced expression in different tissues
--------------------------------------------------------

QPCR was performed to analyze the temporal expression profile of *Lcpis5lt3* in different tissues of healthy large yellow croaker. The results showed that *Lcpis5lt3* exhibited constitutive expression in all examined tissue, including brain, muscle, liver, intestine, gill, kidney, head kidney, and spleen. The highest expression level of *Lcpis5lt3* was detected in the spleen, followed by the head kidney and kidney ([Figure 3A](#F3-ZoolRes-37-6-347){ref-type="fig"}). After *V. alginolyticus* infection, the mRNA expression of *Lcpis5lt3* was rapidly upregulated in liver, head kidney, gill, kidney, and intestine at 4, 8, 12, and 24 hpi, whereas no significant changes were found in the spleen at 4, 8, 12, and 24 hpi ([Figure 3B](#F3-ZoolRes-37-6-347){ref-type="fig"}).

![QPCR analysis of Lcpis5lt3 mRNA expression in different tissues](ZoolRes-37-6-347-g3){#F3-ZoolRes-37-6-347}

Effect of Lcpis5lt3 on the survival rate of *V. alginolyticus*-infected fish
----------------------------------------------------------------------------

We investigated the bactericidal effects of synthesized mature peptide *in vivo* by monitoring the survival of large yellow croaker infected with *V. alginolyticus* prior to treatment with different concentrations of Lcpis5lt3. All PBS-treated large yellow croaker infected with *V. alginolyticus* died within 7 d after infection. Large yellow croaker treatment with Lcpis5lt3 decreased the mortality rate ([Figure 4](#F4-ZoolRes-37-6-347){ref-type="fig"}). At 8 d after *V. alginolyticus* infection, the survival rates were 6% and 50% for large yellow croaker treated with 0.1 μg/g and 1.0 μg/g Lcpis5lt3, respectively ([Figure 4](#F4-ZoolRes-37-6-347){ref-type="fig"}).

![Effect of Lcpis5lt3 on the survival rate of large yellow croaker](ZoolRes-37-6-347-g4){#F4-ZoolRes-37-6-347}

Bacterial burden in tissues and blood
-------------------------------------

To examine the impact of the synthesized mature peptide of Lcpis5lt3 on bacterial proliferation and dissemination *in vivo*, the bacterial loads were quantitated in the liver, spleen, kidney, and blood following ip-injection with 0.1 μg/g Lcpis5lt3 or 1.0 μg/g Lcpis5lt3 in *V. alginolyticus*-challenged fish. Fish treated with 0.1 μg/g Lcpis5lt3 and 1.0 μg/g Lcpis5lt3 all showed a reduction in *V. alginolyticus* load in the liver, spleen, kidney, and blood 12 hpi after *V. alginolyticus* challenge in comparison with the PBS-treated control group ([Figure 5](#F5-ZoolRes-37-6-347){ref-type="fig"}). There were significant differences between the control and 1.0 μg/g Lcpis5lt3 groups in all tested tissues, whereas the 0.1 μg/g Lcpis5lt3-treated group showed only small variation ([Figure 5](#F5-ZoolRes-37-6-347){ref-type="fig"}).

![Effect of Lcpis5lt3 on bacterial burden in large yellow croaker liver, spleen, kidney, and blood](ZoolRes-37-6-347-g5){#F5-ZoolRes-37-6-347}

Effect of Lcpis5lt3 on cytokine expression following infection
--------------------------------------------------------------

To explore the effect of Lcpis5lt3 on inflammatory gene expression *in vivo*, the mRNA levels for inflammatory cytokines LcTNF-α, LcIL-1β, and LcIL-10 were evaluated in tissues collected from the fish after Lcpis5lt3 treatment and PBS-treated controls following infection with *V. alginolyticus*. QPCR analysis revealed a significant decrease in the expressions of LcTNF-α, LcIL-1β, and LcIL-10 transcripts in the tissues of fish treated with 0.1 μg/g or 1.0 μg/g Lcpis5lt3 compared with fish treated with PBS ([Figure 6](#F6-ZoolRes-37-6-347){ref-type="fig"}).

![Effect of Lcpis5lt3 on mRNA levels of LcTNF-α, LcIL-1β, and LcIL-10](ZoolRes-37-6-347-g6){#F6-ZoolRes-37-6-347}

DISCUSSION
==========

In the present study, *Lcpis5lt3* was identified and characterized in large yellow croaker. Lcpis5lt3 comprised a signal peptide, mature peptide, and prodomain, as shared by other piscidin paralogues ([@b2-ZoolRes-37-6-347]; [@b25-ZoolRes-37-6-347]). Similar to other piscidins ([@b44-ZoolRes-37-6-347]), Lcpis5lt3 showed more conservation in the signal peptide and less conservation in the mature peptide and prodomain. The phylogenetic tree confirmed that Lcpis5lt3 was grouped together with large yellow croaker piscidin-5-like type 2 and piscidin-5-like to form a cluster. This result revealed that large yellow croaker pis5lt3 was a variation type of the piscidin-5-like peptide. According to previous research, several piscidin paralogues can be found in a single fish species. For example, piscidin-4 and piscidin-5 genes are found in hybrid striped bass ([@b31-ZoolRes-37-6-347]); piscidin-1, piscidin-2, piscidin-3, piscidin-4, and piscidin-5 genes are found in tilapia ([@b27-ZoolRes-37-6-347]); and piscidin-1, piscidin-2, and piscidin-2-β genes are found in Atlantic cod ([@b30-ZoolRes-37-6-347]). There are also several piscidin genes found in large yellow croaker, such as piscidin-like, piscidin-5-like, and piscidin-5-like type 2 ([@b44-ZoolRes-37-6-347]). These results show a high diversity of piscidin in different fish.

The transcripts of piscidin genes are widely distributed in various tissues ([@b2-ZoolRes-37-6-347]; [@b31-ZoolRes-37-6-347]). In rock bream, the piscidin gene is highly expressed in the gills of healthy fish ([@b1-ZoolRes-37-6-347]). In tilapia, piscidin-2 is abundant in the skin, head kidney, and spleen; piscidin-3 is abundant in the skin, head kidney, and gill; and piscidin-4 is abundant in the intestine ([@b27-ZoolRes-37-6-347]). In the large yellow croaker, the piscidin-like gene is most abundantly expressed in the gill of unchallenged fish ([@b25-ZoolRes-37-6-347]), and the piscidin-5-like is most abundant in the head kidney ([@b44-ZoolRes-37-6-347]). In this study, the *Lcpis5lt3* transcript was highly expressed in the spleen, head kidney, and kidney of the large yellow croaker, suggesting that piscidin genes have a variety of tissue expression patterns. In mandarin fish, piscidin gene mRNA expression is upregulated in the intestine, spleen, kidney, liver, skin, and gill after stimulation with LPS ([@b36-ZoolRes-37-6-347]). In large yellow croaker, piscidin-like gene mRNA expression is significantly upregulated in the gill, skin, spleen, head kidney, liver, and intestine after *C. irritans* infection ([@b25-ZoolRes-37-6-347]). In the current study, the mRNA expression levels of *Lcpis5lt3* were upregulated in the liver, head kidney, gill, kidney, and intestine after *V. alginolyticus* infection. These results suggest that most fish piscidin in a variety of tissues were upregulated after infection. Furthermore, we found there were no significant changes in *Lcpis5lt3* in the spleen after infection. However, this mechanism needs further investigation.

Unique for the field of fish research, AMPs have potential applications to prevent pathogenic microbes in aquaculture ([@b22-ZoolRes-37-6-347]). The constant risk of large-scale microbial infection that can lead to significant economic losses requires new strategies to prevent or treat these pathogens ([@b22-ZoolRes-37-6-347]). In rock bream, the synthetic piscidin peptide exhibits antimicrobial activity against *E. tarda*, *V. vuln ificus*, *V. harveyi*, and *S. iniae* ([@b1-ZoolRes-37-6-347]). In tilapia, five synthetic piscidin peptides have been shown to exhibit antimicrobial activity against *V. vulnificus*, *V. alginolyticus*, *A. hydrophila*, and *Pseudomonas aeruginosa* ([@b27-ZoolRes-37-6-347]). In contrast, our results showed that Lcpis5lt3 had no effect on *E. tarda*, *V. vulnificus*, *V. harveyi*, or *S. iniae* at the antimicrobial activity tested. However, Lcpis5lt3 exhibited antimicrobial activity against *L. monocytogenes*, *S. aureus*, *V. anguillarum*, *V. alginolyticus*, *V. parahaemolyticus*, and *A. hydrophila in vitro*. These results demonstrate that Lcpis5lt3 possesses broad-spectrum antimicrobial activity, and different piscidins in teleosts possess spectrum variety in antimicrobial activity.

To evaluate the antimicrobial activity of Lcpis5lt3 against *V. alginolyticus in vivo*, we performed the survival rate assay. Our results showed that the synthesized mature peptide of Lcpis5lt3 can increase the survival rate of fish infected with *V. alginolyticus* at different concentrations. The overall survival rate of the 1.0 μg/g Lcpis5lt3 group was higher than that of the 0.1 μg/g Lcpis5lt3 group after infection; this effect was accompanied by a lower bacterial burden and a decline in LcTNF-α, LcIL-1β, and LcIL-10 mRNA expression. The cytokines TNF-α and IL-1β in teleosts are powerful proinflammatory cytokines released by several immune cells during infection or tissue damage and are involved in a diverse range of inflammatory and infectious conditions ([@b29-ZoolRes-37-6-347]; [@b34-ZoolRes-37-6-347]; [@b42-ZoolRes-37-6-347]). However, IL-10 is a critical anti-inflammatory cytokine, whose expression is induced after proinflammatory mediators. It helps control immune responses and thereby minimize tissue damage ([@b33-ZoolRes-37-6-347]; [@b40-ZoolRes-37-6-347]; [@b45-ZoolRes-37-6-347]). As an autoregulatory mediator, IL-10 has important regulatory effects on immunological and inflammatory responses due to its capacity to inhibit the production of proinflammatory cytokines by monocytes ([@b28-ZoolRes-37-6-347]). In this study, we found that LcTNF-α, LcIL-1β, and LcIL-10 mRNA expression were all downregulated in the 0.1μg/g and 1.0 μg/g Lcpis5lt3 groups after infection, suggesting that inflammation in fish after *V.alginolyticus* infection was relieved. Similar results were found with tilapia piscidin-4 (TP4). For example, mice treated with TP4 resulted in the downregulation of TNF-α, IL-1β, and IL-10 ([@b24-ZoolRes-37-6-347]). However, it is still unclear whether piscidins can directly downregulate inflammatory cytokines, such as the AMPS of other fish ([@b5-ZoolRes-37-6-347]; [@b17-ZoolRes-37-6-347]), or only kill pathogens to reduce the expression of inflammatory cytokines. Further investigation is needed to elucidate the role of Lcpis5lt3 in the immune responses of large yellow croaker after infection.

In conclusion, we characterized *Lcpis5lt3* as a member of the piscidin family in large yellow croaker. Results showed that *V. alginolyticus* infection led to the alteration of *Lcpis5lt3* mRNA expression in different tissues. Antimicrobial assays *in vitro* and *in vivo* also showed that the synthetic mature peptide had broad spectrum antimicrobial activity *in vitro* and increased fish survival upon bacterial infection *in vivo*. These data provide new insights into the innate immunity of large yellow croaker against pathogens and reveal the value of piscidin as a therapeutic agent to control microbial infections.
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